Drug · DIN 02555093
BICNU
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since March 11, 2026; first marketed April 14, 2025.
- Drug Identification Number (DIN)
- 02555093
- Company (DIN owner)
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Carmustine L01AD01
- Class
- Human
- Record last updated
- April 9, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CARMUSTINE | 100 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 5, 2025: NOC 34790Supplement to a New Drug Submission (SNDS) · Addition of new dosage form: [intravenous solution]
Other DINs named BICNU
- DIN 00297763 · Marketed